Aclaris Therapeutics, Inc. (LON:0H8T)
London · Delayed Price · Currency is GBP · Price in USD 3.300
-0.068 (-2.02%)
At close: Feb 12, 2026
Aclaris Therapeutics Market Cap
Aclaris Therapeutics has a market cap or net worth of 267.24 million as of February 12, 2026. Its market cap has increased by 29.94% in one year.
Market Cap
267.24M
Enterprise Value
146.14M
Revenue
11.71M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.30
Market Cap Chart
Since October 7, 2015, Aclaris Therapeutics's market cap has increased from 140.05M to 267.24M, an increase of 90.82%. That is a compound annual growth rate of 6.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 269.19M | 11.10% |
| Dec 31, 2025 | 242.31M | 14.30% |
| Dec 31, 2024 | 212.00M | 263.06% |
| Dec 29, 2023 | 58.39M | -93.30% |
| Dec 30, 2022 | 871.66M | 32.58% |
| Dec 31, 2021 | 657.46M | 223.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 229.82B |
| GSK plc | 86.28B |
| Haleon | 36.19B |
| Smith & Nephew | 10.90B |
| PureTech Health | 311.77M |
| NIOX Group | 272.49M |
| Avacta Group | 260.26M |
| Integrated Diagnostics Holdings | 259.90M |